Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Technivie + Ribavirin in HCV GT4 and ESKD
NCT03499639Phase 4Completed
- Sponsor
- Assiut University
- Start
- May 2018
- Primary completion
- Aug 2018
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ombitasvir, paritaprevir, ritonavir in Hepatitis C genotype 4 (HCV-4), sponsored by Assiut University. Started May 2018; status: completed.
02
Drugs
ombitasvirparitaprevirritonavir
03
Conditions
Hepatitis C genotype 4 (HCV-4)
Beyond the preview
Go deeper on NCT03499639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499639.